Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong - the HONG KONG PECT Registry

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

This retrospective cohort study (Hong Kong PECT Registry) compares treatment outcomes between different percutaneous catheter-based therapies in patients with acute pulmonary embolism (PE). PE is a critical condition with potential for rapid deterioration and mortality before treatment. While availability of catheter-based therapy contributed to the declining mortality rates of PE, selecting the appropriate intervention remains key. There are primarily two modes of therapies available: Catheter-directed thrombolysis and Aspiration thrombectomy (e.g., Penumbra, Flowtriever, AlphaVac) Given limited direct comparisons between these methods, the study will evaluate their efficacy, safety, and clinical outcomes of these treatment strategies in acute PE patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients who is admitted with a diagnosis of acute pulmonary embolism

• Patient who receives any types of catheter-based therapy for acute pulmonary embolism.

Locations
Other Locations
Hong Kong Special Administrative Region
Prince of Wales Hospital
RECRUITING
Hong Kong
Contact Information
Primary
GuangMing Tan
gtan@cuhk.edu.hk
852 +55699658
Time Frame
Start Date: 2022-06-01
Estimated Completion Date: 2032-12-30
Participants
Target number of participants: 1000
Treatments
catheter-directed thrombolysis (CDT)
Patient treated by any mode of catheter-directed thrombolysis, including ultrasound assisted catheter directed thrombolysis (EKOS).
Aspiration thrombectomy (AT)
Patient treated by any mode of aspiration thrombectomy, including large-bore mechanical thrombectomy (LBMT) such as Penumbra, Flowtriever, or Alphavac.
Related Therapeutic Areas
Sponsors
Leads: Chinese University of Hong Kong
Collaborators: China Medical University, Taiwan

This content was sourced from clinicaltrials.gov

Similar Clinical Trials